VP of $CRS sells 3,900 shares in insider sale

Elizabeth A Socci, the Vice President of $CRS, recently sold 3,900 shares of the company on November 26, 2025, totaling an estimated $1,252,860. This sale represents approximately 28.9% of Socci’s shares of this class of stock. Following this transaction, Socci now holds 9,594 shares of $CRS stock in this class.

Insider trading activity within $CRS has been notable, with insiders engaging in 7 trades on the open market in the last 6 months. These trades consisted of 7 sales and 0 purchases. The breakdown of recent trading activities by insiders includes Tony R. Thene, the President and CEO, who sold 19,000 shares for an estimated $4,654,838. Additionally, I. Martin Inglis sold 5,691 shares for $1,391,704, while Steven E. Karol sold 3,433 shares for $843,772. Ramin Younessi sold 1,300 shares for $399,347, and Anastasios John Hart sold 1,000 shares for $243,725.

Tracking insider transactions can provide valuable insights into market movements, and interested individuals can monitor such activities through Quiver Quantitative’s insider trading dashboard.

Looking at hedge fund activity in relation to $CRS, 320 institutional investors have added shares of the stock to their portfolio, while 312 have decreased their positions in the most recent quarter. Noteworthy movements include FMR LLC removing 1,400,745 shares from their portfolio in Q3 2025, totaling approximately $343,938,927. On the other hand, Castle Hook Partners LP removed 1,034,097 shares from their portfolio for an estimated $253,912,177, while BlackRock, Inc. added 956,896 shares to their portfolio, a 20% increase, totaling $234,956,243.

Analyzing Wall Street analyst reports on $CRS reveals that 5 firms have issued buy ratings on the stock, with no sell ratings reported. Recent analyst ratings include Keybanc’s “Overweight” rating on November 13, 2025, TD Cowen’s “Buy” rating on October 24, 2025, and Jones Trading’s “Buy” rating on October 22, 2025. JP Morgan issued an “Overweight” rating on June 17, 2025, and Benchmark issued a “Buy” rating on June 9, 2025.

Various analysts have provided price targets for $CRS, with a median target of $372.5 based on 6 recent projections. These targets include Philip Gibbs setting a target price of $380.0 on November 13, 2025, Bennett Moore setting a target price of $388.0 on October 29, 2025, and Andre Madrid setting a target price of $365.0 on October 27, 2025. Gautam Khanna set a target price of $340.0 on October 24, 2025, while Josh Sullivan from Jones Trading set a target price of $400.0 on October 22, 2025, and Josh Sullivan from Benchmark set a target price of $300.0 on June 9, 2025.

It is important to note that this article does not provide financial advice. For more information, refer to Quiver Quantitative’s disclaimers.